Cargando…
Meta-analysis of CYP2C19 and CYP2D6 metabolic activity on antidepressant response from 13 clinical studies
Cytochrome P450 enzymes including CYP2C19 and CYP2D6 are important for antidepressant metabolism and polymorphisms of these genes have been determined to predict metabolite levels. Nonetheless, more evidence is needed to understand the impact of genetic variations on antidepressant response. In this...
Autores principales: | Li, Danyang, Pain, Oliver, Fabbri, Chiara, Wong, Win Lee Edwin, Lo, Chris Wai Hang, Ripke, Stephan, Cattaneo, Annamaria, Souery, Daniel, Dernovsek, Mojca Z., Henigsberg, Neven, Hauser, Joanna, Lewis, Glyn, Mors, Ole, Perroud, Nader, Rietschel, Marcella, Uher, Rudolf, Maier, Wolfgang, Aitchison, Katherine J., Baune, Bernhard T., Biernacka, Joanna M., Bondolfi, Guido, Domschke, Katharina, Kato, Masaki, Liu, Yu-Li, Serretti, Alessandro, Tsai, Shih-Jen, Weinshilboum, Richard, McIntosh, Andrew M., Lewis, Cathryn M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327261/ https://www.ncbi.nlm.nih.gov/pubmed/37425775 http://dx.doi.org/10.1101/2023.06.26.23291890 |
Ejemplares similares
-
Methodology for clinical genotyping of CYP2D6 and CYP2C19
por: Carvalho Henriques, Beatriz, et al.
Publicado: (2021) -
Correction: Methodology for clinical genotyping of CYP2D6 and CYP2C19
por: Henriques, Beatriz Carvalho, et al.
Publicado: (2022) -
Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables
por: Iniesta, Raquel, et al.
Publicado: (2018) -
Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP)
por: Ren, Hongyan, et al.
Publicado: (2018) -
Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: Clinical description and the role of the 5-HTTLPR
por: Strohmaier, Jana, et al.
Publicado: (2011)